Article Information
History
- June 13, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kun Wang1,2,
- Jiangshan Shi2,3,
- Xiaochu Tong2,3,
- Ning Qu2,3,
- Xiangtai Kong2,3,
- Shengkun Ni2,3,
- Jing Xing4,
- Xutong Li2,3,* and
- Mingyue Zheng1,2,3,*
- 1School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China
- 2Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences; 555 Zuchongzhi Road, Shanghai 201203, China
- 3University of Chinese Academy of Sciences; No. 19A Yuquan Road, Beijing 100049, China
- 4Lingang Laboratory, Shanghai 200031, China
- ↵*Corresponding author. M. Zheng, School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China. E-mail: myzheng{at}simm.ac.cn; X. Li, Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences; 555 Zuchongzhi Road, Shanghai 201203, China. E-mail addresses: lixutong{at}simm.ac.cn.
Posted June 13, 2023.
TG468: A Text Graph Convolutional Network for Predicting Clinical Response to Immune Checkpoint Inhibitor Therapy
